2025 second_quarter Filing
RRFiled
June 10, 2025
Lobbying Activities
PharmacyView all
FDA modernization policy issues General issues related to rare disease and clinical trials General issues related to diagnostics for patients with rare diseases Issues related to drug pricing Issues related to reform of pharmacy benefit managers Issues related to trade Issues related to Newborn Screening and Genetic Testing
Lobbyists (1)
EDWARD BUCKLEY
NewForeign Entities
KYOWA KIRIN CO., LTD
JP0Ownership: 100%